Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1148920090430010060
Nuclear Medicine and Molecular Imaging
2009 Volume.43 No. 1 p.60 ~ p.71
Image-Based Assessment and Clinical Significance of Absorbed Radiation Dose to Tumor in Repeated High-Dose 131I Anti-CD20 Monoclonal Antibody (Rituximab) Radioimmunotherapy for Non-Hodgkin¡¯s Lymphoma
Byun Byun-Hyun

Cheon Gi-Jeong
Choi Chang-Woon
Lim Sang-Moo
Woo Sang-Keun
Kim Kyeong-Min
Kang Hye-Jin
Kim Byung-Il
Choi Tae-Hyun
Oh Dong-Hyun
Abstract
Purpose: We assessed the absorbed dose to the tumor (Dosetumor) by using pretreatment FDG-PET and whole-body (WB) planar images in repeated radioimmunotherapy (RIT) with 131I rituximab for NHL.

Materials and Methods: Patients with NHL (n=4) were administered a therapeutic dose of 131I rituximab. Serial WB planar images after RIT were acquired and overlaid to the coronal maximum intensity projection (MIP) PET image before RIT. On registered MIP PET and WB planar images, 2D-ROIs were drawn on the region of tumor (n=7) and left medial thigh as background, and Dosetumor was calculated. The correlation between Dosetumor and the CT-based tumor volume change after RIT was analyzed. The differences of Dosetumor and the tumor volume change according to the number of RIT were also assessed.

Results: The values of absorbed dose were 397.7¡¾646.2cGy (53.0¢¦2853.0cGy). The values of CT-based tumor volume were 11.3¡¾9.1 cc (2.9¢¦34.2cc), and the % changes of tumor volume before and after RIT were -29.8¡¾44.3% (-100.0%¢¦+42.5%), respectively. Dosetumor and the tumor volume change did not show the linear relationship (p>0.05). Dosetumor and the tumor volume change did not correlate with the number of repeated administration (p>0.05).

Conclusion: We could determine the position and contour of viable tumor by MIP PET image. And, registration of PET and gamma camera images was possible to estimate the quantitative values of absorbed dose to tumor.
KEYWORD
Radioimmunotherapy, dosimetry, PET, PET/CT, lymphoma
FullTexts / Linksout information
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø